These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 28317559)
1. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study. Seagle BL; Sobecki-Rausch J; Strohl AE; Shilpi A; Grace A; Shahabi S Gynecol Oncol; 2017 Apr; 145(1):61-70. PubMed ID: 28317559 [TBL] [Abstract][Full Text] [Related]
2. Stage I uterine carcinosarcoma: Matched cohort analyses for lymphadenectomy, chemotherapy, and brachytherapy. Seagle BL; Kanis M; Kocherginsky M; Strauss JB; Shahabi S Gynecol Oncol; 2017 Apr; 145(1):71-77. PubMed ID: 28317560 [TBL] [Abstract][Full Text] [Related]
3. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study. Seagle BL; Kanis M; Strohl AE; Shahabi S Gynecol Oncol; 2016 Dec; 143(3):636-641. PubMed ID: 27771166 [TBL] [Abstract][Full Text] [Related]
4. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study. Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707 [TBL] [Abstract][Full Text] [Related]
5. Ovarian granulosa cell tumor: A National Cancer Database study. Seagle BL; Ann P; Butler S; Shahabi S Gynecol Oncol; 2017 Aug; 146(2):285-291. PubMed ID: 28532858 [TBL] [Abstract][Full Text] [Related]
6. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study. Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015 [TBL] [Abstract][Full Text] [Related]
7. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study. Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059 [TBL] [Abstract][Full Text] [Related]
8. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850 [TBL] [Abstract][Full Text] [Related]
9. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Giuntoli RL; Metzinger DS; DiMarco CS; Cha SS; Sloan JA; Keeney GL; Gostout BS Gynecol Oncol; 2003 Jun; 89(3):460-9. PubMed ID: 12798712 [TBL] [Abstract][Full Text] [Related]
10. Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study. Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K J Reprod Med; 2003 Feb; 48(2):95-100. PubMed ID: 12621792 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients. Mancari R; Signorelli M; Gadducci A; Carinelli S; De Ponti E; Sesana S; Corso S; Chiappa V; Colombo N; Lissoni AA Gynecol Oncol; 2014 Jun; 133(3):531-6. PubMed ID: 24631454 [TBL] [Abstract][Full Text] [Related]
13. Uterine serous carcinoma: a historic evaluation of therapy. de Leeuw Fa; Rijcken Fe; Trum Jw; van der Noort V; Tjon-Kon-Fat Ri; Bleeker Mc; Kenter Gg Eur J Gynaecol Oncol; 2016; 37(2):211-5. PubMed ID: 27172747 [TBL] [Abstract][Full Text] [Related]
14. The role of adjuvant therapy in uterine leiomyosarcoma. Ducie JA; Leitao MM Expert Rev Anticancer Ther; 2016; 16(1):45-55. PubMed ID: 26558647 [TBL] [Abstract][Full Text] [Related]
15. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand. Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849 [TBL] [Abstract][Full Text] [Related]
16. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573 [TBL] [Abstract][Full Text] [Related]
17. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease. Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425 [TBL] [Abstract][Full Text] [Related]
18. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418 [TBL] [Abstract][Full Text] [Related]
19. Malignant Mixed Müllerian Tumour of the Uterus: Analysis of 44 Cases. Grasso S; Loizzi V; Minicucci V; Resta L; Camporeale AL; Cicinelli E; Cormio G Oncology; 2017; 92(4):197-204. PubMed ID: 28092915 [TBL] [Abstract][Full Text] [Related]
20. Uterine sarcoma-current management and experience from a regional cancer centre in North India. Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]